{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:24:07Z","timestamp":1793129047107,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["FRGS\/1\/2019\/SKK15\/IMU\/01\/1"],"award-info":[{"award-number":["FRGS\/1\/2019\/SKK15\/IMU\/01\/1"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["FRGS\/1\/2020\/TK0\/UNIM\/03\/3"],"award-info":[{"award-number":["FRGS\/1\/2020\/TK0\/UNIM\/03\/3"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["FRGS\/1\/2023\/SKK10\/UCSI\/02\/1"],"award-info":[{"award-number":["FRGS\/1\/2023\/SKK10\/UCSI\/02\/1"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hubert Curien Partnership \u2013 Hibiscus (PHC-HIBISCUS) France-Malaysia","award":["MyPAIR\/1\/2019\/SKK08\/IMU\/1"],"award-info":[{"award-number":["MyPAIR\/1\/2019\/SKK08\/IMU\/1"]}]},{"name":"Malaysia Ministry of Science, Technology and Innovation Nanotechnology Research Grant","award":["NND\/NA\/1\/TD11-002"],"award-info":[{"award-number":["NND\/NA\/1\/TD11-002"]}]},{"name":"UCSI University Research Excellence and Innovation Grant","award":["REIG-FPS-2023\/038"],"award-info":[{"award-number":["REIG-FPS-2023\/038"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-80646-1","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T13:29:21Z","timestamp":1733232561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Polyethylene glycol-phospholipid functionalized single-walled carbon nanotubes for enhanced siRNA systemic delivery"],"prefix":"10.1038","volume":"14","author":[{"given":"Yuen-Fen","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Wei","family":"Hii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Meng","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon-Keng","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee-Onn","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxine Swee-Li","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Wai","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"key":"80646_CR1","first-page":"570","volume":"14","author":"H Wood","year":"2018","unstructured":"Wood, H. FDA approves patisiran to treat hereditary transthyretin amyloidosis. Nat. Rev. Neurol. 14, 570\u2013570 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"80646_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40265-020-01269-0","volume":"80","author":"LJ Scott","year":"2020","unstructured":"Scott, L. J. Givosiran: first approval. Drugs 80, 335\u2013339 (2020).","journal-title":"Drugs"},{"issue":"7","key":"80646_CR3","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1021\/acs.bioconjchem.3c00205","volume":"34","author":"EA Narasipura","year":"2023","unstructured":"Narasipura, E. A., VanKeulen-Miller, R., Ma, Y. & Fenton, O. S. Ongoing clinical trials of nonviral siRNA therapeutics. Bioconjug. Chem. 34(7), 1177\u20131197 (2023).","journal-title":"Bioconjug. Chem."},{"key":"80646_CR4","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3390\/pharmaceutics13071009","volume":"13","author":"D Hattab","year":"2021","unstructured":"Hattab, D., Gazzali, A. M. & Bakhtiar, A. Clinical advances of siRNA-based nanotherapeutics for cancer treatment. Pharmaceutics 13, 1009 (2021).","journal-title":"Pharmaceutics"},{"key":"80646_CR5","first-page":"528","volume":"19","author":"S Ghosh","year":"2020","unstructured":"Ghosh, S., Firdous, S. M. & Nath, A. siRNA could be a potential therapy for COVID-19. EXCLI J. 19, 528 (2020).","journal-title":"EXCLI J."},{"key":"80646_CR6","doi-asserted-by":"publisher","first-page":"2100108","DOI":"10.1002\/adtp.202100108","volume":"4","author":"T Tieu","year":"2021","unstructured":"Tieu, T., Wei, Y., Cifuentes-Rius, A. & Voelcker, N. H. Overcoming barriers: clinical translation of siRNA nanomedicines. Adv. Ther. 4, 2100108 (2021).","journal-title":"Adv. Ther."},{"key":"80646_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/ph13100294","volume":"13","author":"MI Sajid","year":"2020","unstructured":"Sajid, M. I., Moazzam, M., Kato, S., Yeseom Cho, K. & Tiwari, R. K. Overcoming barriers for siRNA therapeutics: from bench to bedside. Pharmaceuticals 13, 294 (2020).","journal-title":"Pharmaceuticals"},{"key":"80646_CR8","doi-asserted-by":"publisher","first-page":"102239","DOI":"10.1016\/j.nano.2020.102239","volume":"29","author":"MA Subhan","year":"2020","unstructured":"Subhan, M. A. & Torchilin, V. siRNA based drug design, quality, delivery and clinical translation. Nanomedicine 29, 102239 (2020).","journal-title":"Nanomedicine"},{"key":"80646_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ijpharm.2017.03.017","volume":"524","author":"Z Li","year":"2017","unstructured":"Li, Z., de Barros, A. L. B., Soares, D. C. F., Moss, S. N. & Alisaraie, L. Functionalized single-walled carbon nanotubes: cellular uptake, biodistribution and applications in drug delivery. Int. J. Pharm. 524, 41\u201354 (2017).","journal-title":"Int. J. Pharm."},{"key":"80646_CR10","doi-asserted-by":"publisher","first-page":"e20230041","DOI":"10.1002\/INMD.20230041","volume":"2","author":"T Wang","year":"2024","unstructured":"Wang, T., Tang, Y., Tao, Y., Zhou, H. & Ding, D. Nucleic acid drug and delivery techniques for disease therapy: Present situation and future prospect. Interdiscip Med. 2, e20230041 (2024).","journal-title":"Interdiscip Med."},{"key":"80646_CR11","doi-asserted-by":"publisher","first-page":"8096","DOI":"10.1039\/D3TB00278K","volume":"11","author":"C Yan","year":"2023","unstructured":"Yan, C. et al. Design, strategies, and therapeutics in nanoparticle-based siRNA delivery systems for breast cancer. J. Mater. Chem. B. 11, 8096\u20138116 (2023).","journal-title":"J. Mater. Chem. B"},{"key":"80646_CR12","doi-asserted-by":"publisher","first-page":"100006","DOI":"10.1016\/j.nwnano.2023.100006","volume":"1","author":"D Jain","year":"2023","unstructured":"Jain, D., Prajapati, S. K., Jain, A. & Singhal, R. Nano-formulated siRNA-based therapeutic approaches for cancer therapy. Nano Trends. 1, 100006 (2023).","journal-title":"Nano Trends"},{"key":"80646_CR13","doi-asserted-by":"publisher","first-page":"111020","DOI":"10.1016\/j.inoche.2023.111020","volume":"155","author":"H Ijaz","year":"2023","unstructured":"Ijaz, H. et al. Review on carbon nanotubes (CNTs) and their chemical and physical characteristics, with particular emphasis on potential applications in biomedicine. Inorg. Chem. Commun. 155, 111020 (2023).","journal-title":"Inorg. Chem. Commun."},{"key":"80646_CR14","doi-asserted-by":"publisher","first-page":"0148","DOI":"10.34133\/research.0148","volume":"6","author":"C Qiu","year":"2023","unstructured":"Qiu, C. et al. Advanced strategies for overcoming endosomal\/lysosomal barrier in nanodrug delivery. Res 6, 0148 (2023).","journal-title":"Res"},{"key":"80646_CR15","doi-asserted-by":"publisher","first-page":"100036","DOI":"10.1016\/j.pscia.2024.100036","volume":"2","author":"MH Rahman","year":"2024","unstructured":"Rahman, M. H. et al. Additive manufacturing in nano drug delivery systems. Pharm. Sci. Adv. 2, 100036 (2024).","journal-title":"Pharm. Sci. Adv."},{"key":"80646_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-021-01174-y","volume":"19","author":"L Tang","year":"2021","unstructured":"Tang, L. et al. Insights on functionalized carbon nanotubes for cancer theranostics. J. Nanobiotech. 19, 1\u201328 (2021).","journal-title":"J. Nanobiotech"},{"key":"80646_CR17","doi-asserted-by":"publisher","first-page":"5722","DOI":"10.1039\/D1NA00293G","volume":"3","author":"R Dubey","year":"2021","unstructured":"Dubey, R., Dutta, D., Sarkar, A. & Chattopadhyay, P. Functionalized carbon nanotubes: synthesis, properties and applications in water purification, drug delivery, and material and biomedical sciences. Nanoscale Adv. 3, 5722\u20135744 (2021).","journal-title":"Nanoscale Adv."},{"key":"80646_CR18","doi-asserted-by":"publisher","first-page":"112044","DOI":"10.1016\/j.colsurfb.2021.112044","volume":"208","author":"R Chadar","year":"2021","unstructured":"Chadar, R., Afzal, O., Alqahtani, S. M. & Kesharwani, P. Carbon nanotubes as an emerging nanocarrier for the delivery of doxorubicin for improved chemotherapy. Colloids Surf. B Biointerfaces. 208, 112044 (2021).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"80646_CR19","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.1039\/D0OB01101K","volume":"18","author":"AS Skwarecki","year":"2020","unstructured":"Skwarecki, A. S., Nowak, M. G. & Milewska, M. J. Synthetic strategies in construction of organic macromolecular carrier-drug conjugates. Org. Biomol. Chem. 18, 5764\u20135783 (2020).","journal-title":"Org. Biomol. Chem."},{"key":"80646_CR20","doi-asserted-by":"publisher","first-page":"13569","DOI":"10.1039\/c3ra40852c","volume":"3","author":"D Ravelli","year":"2013","unstructured":"Ravelli, D. et al. PEGylated carbon nanotubes: preparation, properties and applications. RSC Adv. 3, 13569\u201313582 (2013).","journal-title":"RSC Adv."},{"key":"80646_CR21","doi-asserted-by":"publisher","first-page":"215794","DOI":"10.1016\/j.canlet.2022.215794","volume":"543","author":"CW Mai","year":"2022","unstructured":"Mai, C. W. et al. Modeling prostate cancer: what does it take to build an ideal tumor model? Cancer Lett. 543, 215794 (2022).","journal-title":"Cancer Lett."},{"key":"80646_CR22","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1021\/acs.nanolett.0c00752","volume":"20","author":"NRM Saunders","year":"2020","unstructured":"Saunders, N. R. M. et al. A nanoprimer to improve the systemic delivery of siRNA and mRNA. Nano Lett. 20, 4264\u20134269 (2020).","journal-title":"Nano Lett."},{"key":"80646_CR23","doi-asserted-by":"publisher","first-page":"20045","DOI":"10.1039\/C9NR04795F","volume":"11","author":"J Karlsson","year":"2019","unstructured":"Karlsson, J. et al. Engineered nanoparticles for systemic siRNA delivery to malignant brain tumours. Nanoscale 11, 20045\u201320057 (2019).","journal-title":"Nanoscale"},{"key":"80646_CR24","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1248\/bpb.b19-00032","volume":"42","author":"F Song","year":"2019","unstructured":"Song, F. et al. Design of a novel PEGylated liposomal vector for systemic delivery of siRNA to solid tumors. Biol. Pharm. Bull. 42, 996\u20131003 (2019).","journal-title":"Biol. Pharm. Bull."},{"key":"80646_CR25","doi-asserted-by":"publisher","unstructured":"Chung, S. L. et al. Advances in nanomaterials used in co-delivery of siRNA and small molecule drugs for cancer treatment. Nanomater 11 https:\/\/doi.org\/10.3390\/nano11102467 (2021).","DOI":"10.3390\/nano11102467"},{"key":"80646_CR26","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3390\/ma14051059","volume":"14","author":"J Jampilek","year":"2021","unstructured":"Jampilek, J. & Kralova, K. Advances in drug delivery nanosystems using graphene-based materials and carbon nanotubes. Materials 14, 1059 (2021).","journal-title":"Materials"},{"key":"80646_CR27","doi-asserted-by":"publisher","first-page":"101811","DOI":"10.1016\/j.jddst.2020.101811","volume":"58","author":"R Jha","year":"2020","unstructured":"Jha, R., Singh, A., Sharma, P. & Fuloria, N. K. Smart carbon nanotubes for drug delivery system: a comprehensive study. J. Drug Deliv Sci. Technol. 58, 101811 (2020).","journal-title":"J. Drug Deliv Sci. Technol."},{"key":"80646_CR28","doi-asserted-by":"publisher","first-page":"101892","DOI":"10.1016\/j.jddst.2020.101892","volume":"59","author":"AR Kiran","year":"2020","unstructured":"Kiran, A. R., Kumari, G. K. & Krishnamurthy, P. T. Carbon nanotubes in drug delivery: focus on anticancer therapies. J. Drug Deliv Sci. Technol. 59, 101892 (2020).","journal-title":"J. Drug Deliv Sci. Technol."},{"key":"80646_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00204-014-1376-6","volume":"90","author":"LC Ong","year":"2016","unstructured":"Ong, L. C., Chung, F. F., Tan, Y. F. & Leong, C. O. Toxicity of single-walled carbon nanotubes. Arch. Toxicol. 90, 103\u2013118. https:\/\/doi.org\/10.1007\/s00204-014-1376-6 (2016).","journal-title":"Arch. Toxicol."},{"key":"80646_CR30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.taap.2017.06.024","volume":"329","author":"LC Ong","year":"2017","unstructured":"Ong, L. C. et al. Single-walled carbon nanotubes (SWCNTs) inhibit heat shock protein 90 (HSP90) signaling in human lung fibroblasts and keratinocytes. Toxicol. Appl. Pharmacol. 329, 347\u2013357 (2017).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"80646_CR31","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/01480545.2019.1709492","volume":"45","author":"SK Prajapati","year":"2022","unstructured":"Prajapati, S. K., Malaiya, A., Kesharwani, P., Soni, D. & Jain, A. Biomedical applications and toxicities of carbon nanotubes. Drug Chem. Toxicol. 45, 435\u2013450 (2022).","journal-title":"Drug Chem. Toxicol."},{"key":"80646_CR32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jpha.2019.04.003","volume":"9","author":"D Mohanta","year":"2019","unstructured":"Mohanta, D., Patnaik, S., Sood, S. & Das, N. Carbon nanotubes: evaluation of toxicity at biointerfaces. J. Pharm. Anal. 9, 293\u2013300 (2019).","journal-title":"J. Pharm. Anal."},{"key":"80646_CR33","doi-asserted-by":"publisher","first-page":"10179","DOI":"10.2147\/IJN.S220087","volume":"14","author":"H Yan","year":"2019","unstructured":"Yan, H. et al. Toxicity of carbon nanotubes as anti-tumor drug carriers. Int. J. Nanomed. 14, 10179\u201310194 (2019).","journal-title":"Int. J. Nanomed."},{"key":"80646_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1021\/acs.chemrestox.0c00172","volume":"34","author":"MA Saleemi","year":"2020","unstructured":"Saleemi, M. A. et al. Toxicity of carbon nanotubes: molecular mechanisms, signaling cascades, and remedies in biomedical applications. Chem. Res. Toxicol. 34, 24\u201346 (2020).","journal-title":"Chem. Res. Toxicol."},{"key":"80646_CR35","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s13346-019-00631-4","volume":"9","author":"Z Hussain","year":"2019","unstructured":"Hussain, Z. et al. PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution. Drug Deliv Transl Res. 9, 721\u2013734 (2019).","journal-title":"Drug Deliv Transl Res."},{"key":"80646_CR36","doi-asserted-by":"publisher","unstructured":"Guo, C. et al. The interplay between PEGylated nanoparticles and blood immune system. Adv. Drug Deliv Rev. 115044 https:\/\/doi.org\/10.1016\/j.addr.2023.115044 (2023).","DOI":"10.1016\/j.addr.2023.115044"},{"key":"80646_CR37","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/09205063.2020.1825304","volume":"32","author":"D Yadav","year":"2021","unstructured":"Yadav, D. & Dewangan, H. K. Peglyation: an important approach for novel drug delivery system. J. Biomater. Sci. Polym. Ed. 32, 266\u2013280 (2021).","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"80646_CR38","doi-asserted-by":"publisher","first-page":"16958","DOI":"10.1021\/ja505986a","volume":"136","author":"JK Nair","year":"2014","unstructured":"Nair, J. K. et al. Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing. J. Am. Chem. Soc. 136, 16958\u201316961 (2014).","journal-title":"J. Am. Chem. Soc."},{"key":"80646_CR39","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1517\/17425240902878010","volume":"6","author":"C Lin","year":"2009","unstructured":"Lin, C. & Engbersen, J. F. The role of the disulfide group in disulfide-based polymeric gene carriers. Expert Opin. Drug Deliv. 6, 421\u2013439 (2009).","journal-title":"Expert Opin. Drug Deliv"},{"key":"80646_CR40","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0169-409X(02)00179-5","volume":"55","author":"G Saito","year":"2003","unstructured":"Saito, G., Swanson, J. A. & Lee, K. D. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv. Drug Deliv Rev. 55, 199\u2013215 (2003).","journal-title":"Adv. Drug Deliv Rev."},{"key":"80646_CR41","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1021\/ar200248u","volume":"45","author":"S Son","year":"2012","unstructured":"Son, S., Namgung, R., Kim, J., Singha, K. & Kim, W. J. Bioreducible polymers for gene silencing and delivery. Acc. Chem. Res. 45, 1100\u20131112 (2012).","journal-title":"Acc. Chem. Res."},{"key":"80646_CR42","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.drudis.2013.11.004","volume":"19","author":"HL Perez","year":"2014","unstructured":"Perez, H. L. et al. Antibody-drug conjugates: current status and future directions. Drug Discov Today. 19, 869\u2013881 (2014).","journal-title":"Drug Discov Today"},{"key":"80646_CR43","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1021\/bc700397x","volume":"19","author":"M Ou","year":"2008","unstructured":"Ou, M. et al. Novel biodegradable poly(disulfide amine)s for gene delivery with high efficiency and low cytotoxicity. Bioconjug. Chem. 19, 626\u2013633 (2008).","journal-title":"Bioconjug. Chem."},{"key":"80646_CR44","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.biomaterials.2008.10.009","volume":"30","author":"TI Kim","year":"2009","unstructured":"Kim, T. I., Ou, M., Lee, M. & Kim, S. W. Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems. Biomaterials 30, 658\u2013664 (2009).","journal-title":"Biomaterials"},{"key":"80646_CR45","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.3748\/wjg.v28.i18.1934","volume":"28","author":"W Sim","year":"2022","unstructured":"Sim, W., Lim, W. M., Hii, L. W., Leong, C. O. & Mai, C. W. Targeting pancreatic cancer immune evasion by inhibiting histone deacetylases. World J. Gastroenterol. 28, 1934\u20131945 (2022).","journal-title":"World J. Gastroenterol."},{"key":"80646_CR46","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1007\/s10565-023-09830-9","volume":"39","author":"CK Looi","year":"2023","unstructured":"Looi, C. K. et al. Targeting the crosstalk of epigenetic modifications and immune evasion in nasopharyngeal cancer. Cell. Biol. Toxicol. 39, 2501\u20132526 (2023).","journal-title":"Cell. Biol. Toxicol."},{"key":"80646_CR47","doi-asserted-by":"publisher","unstructured":"Looi, C. K. et al. Roles of inflammasomes in Epstein-Barr virus-associated nasopharyngeal cancer. Cancers 13 https:\/\/doi.org\/10.3390\/cancers13081786 (2021).","DOI":"10.3390\/cancers13081786"},{"key":"80646_CR48","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.2174\/1389450117666161216125344","volume":"18","author":"CW Mai","year":"2017","unstructured":"Mai, C. W., Chung, F. F. & Leong, C. O. Targeting legumain as a novel therapeutic strategy in cancers. Curr. Drug Targets. 18, 1259\u20131268 (2017).","journal-title":"Curr. Drug Targets"},{"key":"80646_CR49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2174\/1568009616888151112095948","volume":"16","author":"FF Chung","year":"2016","unstructured":"Chung, F. F., Mai, C. W., Ng, P. Y. & Leong, C. O. Cytochrome P450 2W1 (CYP2W1) in colorectal cancers. Curr. Cancer Drug Targets. 16, 71\u201378 (2016).","journal-title":"Curr. Cancer Drug Targets"},{"key":"80646_CR50","doi-asserted-by":"publisher","unstructured":"Gan, L. L., Hii, L. W., Wong, S. F., Leong, C. O. & Mai, C. W. Molecular mechanisms and potential therapeutic reversal of pancreatic cancer-induced immune evasion. Cancers 12 https:\/\/doi.org\/10.3390\/cancers12071872 (2020).","DOI":"10.3390\/cancers12071872"},{"key":"80646_CR51","doi-asserted-by":"publisher","unstructured":"Looi, C. K., Hii, L. W., Ngai, S. C., Leong, C. O. & Mai, C. W. The Role of Ras-Associated Protein 1 (Rap1) in cancer: Bad actor or good player? Biomedicines 8, doi: https:\/\/doi.org\/10.3390\/biomedicines8090334 (2020).","DOI":"10.3390\/biomedicines8090334"},{"key":"80646_CR52","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.canlet.2021.02.006","volume":"504","author":"K Liew","year":"2021","unstructured":"Liew, K. et al. Parallel genome-wide RNAi screens identify lymphocyte-specific protein tyrosine kinase (LCK) as a targetable vulnerability of cell proliferation and chemoresistance in nasopharyngeal carcinoma. Cancer Lett. 504, 81\u201390 (2021).","journal-title":"Cancer Lett."},{"key":"80646_CR53","doi-asserted-by":"publisher","first-page":"101692","DOI":"10.1016\/j.mtcomm.2020.101692","volume":"25","author":"R Augustine","year":"2020","unstructured":"Augustine, R. et al. Cellular uptake and retention of nanoparticles: insights on particle properties and interaction with cellular components. Mater. Today Comm. 25, 101692 (2020).","journal-title":"Mater. Today Comm."},{"key":"80646_CR54","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.addr.2019.04.008","volume":"143","author":"ND Donahue","year":"2019","unstructured":"Donahue, N. D., Acar, H. & Wilhelm, S. Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine. Adv. Drug Deliv Rev. 143, 68\u201396 (2019).","journal-title":"Adv. Drug Deliv Rev."},{"key":"80646_CR55","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.7150\/thno.30302","volume":"9","author":"W Zhang","year":"2019","unstructured":"Zhang, W. et al. Nano-structural effects on gene transfection: large, botryoid-shaped nanoparticles enhance DNA delivery via macropinocytosis and effective dissociation. Theranostics 9, 1580 (2019).","journal-title":"Theranostics"},{"key":"80646_CR56","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2217\/nnm.09.95","volume":"5","author":"V Raffa","year":"2010","unstructured":"Raffa, V., Ciofani, G., Vittorio, O., Riggio, C. & Cuschieri, A. Physicochemical properties affecting cellular uptake of carbon nanotubes. Nanomedicine 5, 89\u201397 (2010).","journal-title":"Nanomedicine"},{"key":"80646_CR57","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.actbio.2016.11.013","volume":"49","author":"C Caoduro","year":"2017","unstructured":"Caoduro, C. et al. Carbon nanotubes as gene carriers: focus on internalization pathways related to functionalization and properties. Acta Biomater. 49, 36\u201344 (2017).","journal-title":"Acta Biomater."},{"key":"80646_CR58","doi-asserted-by":"publisher","first-page":"6485","DOI":"10.1166\/jnn.2013.7525","volume":"13","author":"N Ma","year":"2013","unstructured":"Ma, N. et al. Influence of nanoparticle shape, size, and surface functionalization on cellular uptake. J. Nanosci. Nanotechnol. 13, 6485\u20136498 (2013).","journal-title":"J. Nanosci. Nanotechnol"},{"issue":"2","key":"80646_CR59","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41571-023-00842-2","volume":"21","author":"A Tuval","year":"2024","unstructured":"Tuval, A., Strandgren, C., Heldin, A., Palomar-Siles, M. & Wiman, K. G. Pharmacological reactivation of p53 in the era of precision anticancer medicine. Nat. Rev. Clin. Oncol. 21(2), 106\u2013120 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"80646_CR60","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mtcomm.2020.101692","volume":"6","author":"JW Keng","year":"2024","unstructured":"Keng, J. W. et al. Cassia alata and its phytochemiaals: A promising natural strategy in wound recovery. Sci 6, 34. https:\/\/doi.org\/10.1016\/j.mtcomm.2020.101692 (2024).","journal-title":"Sci"},{"key":"80646_CR61","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.3390\/nu15081854","volume":"15","author":"KL Pang","year":"2023","unstructured":"Pang, K. L., Mai, C. W. & Chin, K. Y. Molecular mechanism of tocotrienol-mediated anticancer properties: a systematic review of the involvement of endoplasmic reticulum stress and unfolded protein response. Nutrients 15, 1854. https:\/\/doi.org\/10.3390\/nu15081854 (2023).","journal-title":"Nutrients"},{"key":"80646_CR62","doi-asserted-by":"publisher","first-page":"943","DOI":"10.4251\/wjgo.v15.i6.943","volume":"15","author":"SO Ekeuku","year":"2023","unstructured":"Ekeuku, S. O., Etim, E. P., Pang, K. L., Chin, K. Y. & Mai, C. W. Vitamin E in the management of pancreatic cancer: a scoping review. World J. Gastrointest. Oncol. 15, 943\u2013958. https:\/\/doi.org\/10.4251\/wjgo.v15.i6.943 (2023).","journal-title":"World J. Gastrointest. Oncol."},{"key":"80646_CR63","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41565-022-01266-2","volume":"18","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy. Nat. Nanotechnol. 18, 193\u2013204 (2023).","journal-title":"Nat. Nanotechnol"},{"key":"80646_CR64","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2217\/nnm-2020-0374","volume":"16","author":"G Maniam","year":"2021","unstructured":"Maniam, G., Mai, C. W., Zulkefeli, M. & Fu, J. Y. Co-encapsulation of gemcitabine and tocotrienols in nanovesicles enhanced efficacy in pancreatic cancer. Nanomedicine 16, 373\u2013389 (2021).","journal-title":"Nanomedicine"},{"key":"80646_CR65","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.3389\/fphar.2018.01358","volume":"9","author":"G Maniam","year":"2018","unstructured":"Maniam, G. et al. Challenges and opportunities of nanotechnology as delivery platform for tocotrienols in cancer therapy. Front. Pharmacol. 9, 1358 (2018).","journal-title":"Front. Pharmacol."},{"key":"80646_CR66","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1038\/nprot.2009.146","volume":"4","author":"Z Liu","year":"2009","unstructured":"Liu, Z., Tabakman, S. M., Chen, Z. & Dai, H. Preparation of carbon nanotube bioconjugates for biomedical applications. Nat. Protoc. 4, 1372\u20131382 (2009).","journal-title":"Nat. Protoc."},{"key":"80646_CR67","doi-asserted-by":"publisher","first-page":"417","DOI":"10.52547\/rbmb.9.4.417","volume":"9","author":"HH Chan","year":"2021","unstructured":"Chan, H. H. et al. Effects of amyloid precursor protein overexpression on NF-kappaB, Rho-GTPase and pro-apoptosis Bcl-2 pathways in neuronal cells. Rep. Biochem. Mol. Biol. 9, 417\u2013425 (2021).","journal-title":"Rep. Biochem. Mol. Biol."},{"key":"80646_CR68","doi-asserted-by":"publisher","first-page":"12188","DOI":"10.1111\/jcmm.15876","volume":"24","author":"G Nalairndran","year":"2020","unstructured":"Nalairndran, G. et al. Phosphoinositide-dependent kinase-1 (PDPK1) regulates serum\/glucocorticoid-regulated kinase 3 (SGK3) for prostate cancer cell survival. J. Cell. Mol. Med. 24, 12188\u201312198 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"80646_CR69","doi-asserted-by":"publisher","unstructured":"Hii, L. W. et al. Sphingosine kinase 1 regulates the survival of breast cancer stem cells and non-stem breast cancer cells by suppression of STAT1. Cells 9, doi: https:\/\/doi.org\/10.3390\/cells9040886 (2020).","DOI":"10.3390\/cells9040886"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80646-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80646-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80646-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T15:03:43Z","timestamp":1733238223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80646-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["80646"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-80646-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"assertion":[{"value":"5 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30098"}}